Eyenovia Shares Are Trading Higher After the Company Announced the Launch of a New FDA-Approved Ophthalmic Drug Along With Formosa Pharma.
Eyenovia Shares Are Trading Higher After the Company Announced the Launch of a New FDA-Approved Ophthalmic Drug Along With Formosa Pharma.
eyenovia股價上漲，因公司宣佈推出一種新的獲得FDA批准的眼科藥物，以及與福瑪製藥合作。
Eyenovia Shares Are Trading Higher After the Company Announced the Launch of a New FDA-Approved Ophthalmic Drug Along With Formosa Pharma.
Eyenovia宣佈與臺塑製藥一起推出經美國食品藥品管理局批准的新眼科藥物後，該公司股價走高。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。